New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health problems from extra weight and other measurements

Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present framework,

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal.The report introduces two new diagnostic ...

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. The report introduces two new diagnostic ...

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. People with clinical obesity meet BMI and other ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,

Recent study held under Dr. Ziyada Al-Aly found that GLP-1 medications can reduce the risk of disease like heart disease and addiction. The reports direct further investigation to reduce anticipated side effects.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, scientists have found. Last year, research revealed that weight-loss jabs – or GLP-1RAs – such as Wegovy and Ozempic could reduce the risk of heart attack and stroke.

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.